{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:56:44Z","timestamp":1792198604025,"version":"4.4.0"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T00:00:00Z","timestamp":1697155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T00:00:00Z","timestamp":1697155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["ECR\/2018\/000718"],"award-info":[{"award-number":["ECR\/2018\/000718"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Neurobiol"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1007\/s10571-023-01419-4","type":"journal-article","created":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T07:02:23Z","timestamp":1697180543000},"page":"3983-3996","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Retinal Changes in Parkinson\u2019s Disease: A Non-invasive Biomarker for Early Diagnosis"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2780-8539","authenticated-orcid":false,"given":"Mohana Devi","family":"Subramaniam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Aishwarya Janaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Abishek Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janani","family":"Gopalarethinam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aswathy P.","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Mahalaxmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balachandar","family":"Vellingiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,13]]},"reference":[{"key":"1419_CR1","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1136\/jnnp-2022-329342","volume":"94","author":"JN Alves","year":"2023","unstructured":"Alves JN, Westner BU, H\u00f8jlund A, Weil RS, Dalal SS (2023) Structural and functional changes in the retina in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 94:448\u2013456. https:\/\/doi.org\/10.1136\/jnnp-2022-329342","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1419_CR2","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1093\/brain\/awp068","volume":"132","author":"NK Archibald","year":"2009","unstructured":"Archibald NK, Clarke MP, Mosimann UP, Burn DJ (2009) The retina in Parkinson\u2019s disease. Brain 132:1128\u20131145. https:\/\/doi.org\/10.1093\/brain\/awp068","journal-title":"Brain"},{"key":"1419_CR3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ene.14108","volume":"27","author":"R Balestrino","year":"2020","unstructured":"Balestrino R, Schapira AHV (2020) Parkinson disease. Eur J Neurol 27:27\u201342. https:\/\/doi.org\/10.1111\/ene.14108","journal-title":"Eur J Neurol"},{"key":"1419_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.608026","volume":"8","author":"CM Bantle","year":"2021","unstructured":"Bantle CM, Hirst WD, Weihofen A, Shlevkov E (2021) Mitochondrial dysfunction in astrocytes: a role in Parkinson\u2019s disease? Front Cell Dev Biol 8:608026. https:\/\/doi.org\/10.3389\/fcell.2020.608026","journal-title":"Front Cell Dev Biol"},{"key":"1419_CR5","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.neulet.2014.04.027","volume":"571","author":"TG Beach","year":"2014","unstructured":"Beach TG, Carew J, Serrano G, Adler CH, Shill HA, Sue LI, Sabbagh MN, Akiyama H, Cuenca N (2014) Phosphorylated \u03b1-synuclein-immunoreactive retinal neuronal elements in Parkinson\u2019s disease subjects. Neurosci Lett 571:34\u201338. https:\/\/doi.org\/10.1016\/j.neulet.2014.04.027","journal-title":"Neurosci Lett"},{"key":"1419_CR6","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/ng1769","volume":"38","author":"A Bender","year":"2006","unstructured":"Bender A, Krishnan KJ, Morris CM, Taylor GA, Reeve AK, Perry RH, Jaros E, Hersheson JS, Betts J, Klopstock T, Taylor RW, Turnbull DM (2006) High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat Genet 38:515\u2013517. https:\/\/doi.org\/10.1038\/ng1769","journal-title":"Nat Genet"},{"key":"1419_CR7","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.pbb.2011.05.002","volume":"99","author":"LC Bidwell","year":"2011","unstructured":"Bidwell LC, McClernon FJ, Kollins SH (2011) Cognitive enhancers for the treatment of ADHD. Pharmacol Biochem Behav 99:262\u2013274. https:\/\/doi.org\/10.1016\/j.pbb.2011.05.002","journal-title":"Pharmacol Biochem Behav"},{"key":"1419_CR8","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1002\/ana.24182","volume":"75","author":"I Bodis-Wollner","year":"2014","unstructured":"Bodis-Wollner I, Kozlowski PB, Glazman S, Miri S (2014) \u03b1-synuclein in the inner retina in parkinson disease. Ann Neurol 75:964\u2013966. https:\/\/doi.org\/10.1002\/ana.24182","journal-title":"Ann Neurol"},{"key":"1419_CR9","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/jnc.13731","volume":"139","author":"A Bose","year":"2016","unstructured":"Bose A, Beal MF (2016) Mitochondrial dysfunction in Parkinson\u2019s disease. J Neurochem 139:216\u2013231. https:\/\/doi.org\/10.1111\/jnc.13731","journal-title":"J Neurochem"},{"key":"1419_CR10","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1126\/science.112679","volume":"205","author":"TJ Brozoski","year":"1979","unstructured":"Brozoski TJ, Brown RM, Rosvold HE, Goldman PS (1979) Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science 205:929\u2013932. https:\/\/doi.org\/10.1126\/science.112679","journal-title":"Science"},{"key":"1419_CR11","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/cns.12264","volume":"20","author":"A Camilleri","year":"2014","unstructured":"Camilleri A, Vassallo N (2014) The centrality of mitochondria in the pathogenesis and treatment of Parkinson\u2019s disease. CNS Neurosci Ther 20:591\u2013602. https:\/\/doi.org\/10.1111\/cns.12264","journal-title":"CNS Neurosci Ther"},{"key":"1419_CR12","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3233\/JPD-191683","volume":"9","author":"S Cerri","year":"2019","unstructured":"Cerri S, Mus L, Blandini F (2019) Parkinson\u2019s disease in women and men: what\u2019s the difference? J Parkinsons Dis 9:501\u2013515. https:\/\/doi.org\/10.3233\/JPD-191683","journal-title":"J Parkinsons Dis"},{"key":"1419_CR13","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/978-3-211-45295-0_23","volume-title":"Parkinson\u2019s disease and related disorders","author":"AR Chade","year":"2006","unstructured":"Chade AR, Kasten M, Tanner CM (2006) Nongenetic causes of Parkinson\u2019s disease. In: Riederer P, Reichmann H, Youdim MBF, Gerlach M (eds) Parkinson\u2019s disease and related disorders. Springer, Vienna, pp 147\u2013151"},{"key":"1419_CR14","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1093\/hmg\/ddr048","volume":"20","author":"NC Chan","year":"2011","unstructured":"Chan NC, Salazar AM, Pham AH, Sweredoski MJ, Kolawa NJ, Graham RLJ, Hess S, Chan DC (2011) Broad activation of the ubiquitin\u2013proteasome system by Parkin is critical for mitophagy. Hum Mol Genet 20:1726\u20131737. https:\/\/doi.org\/10.1093\/hmg\/ddr048","journal-title":"Hum Mol Genet"},{"key":"1419_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.832768","volume":"14","author":"Z Chang","year":"2022","unstructured":"Chang Z, Xie F, Li H, Yuan F, Zeng L, Shi L, Zhu S, Lu X, Wei X, Wang Q (2022) Retinal nerve fiber layer thickness and associations with cognitive impairment in Parkinson\u2019s disease. Front Aging Neurosci 14:832768. https:\/\/doi.org\/10.3389\/fnagi.2022.832768","journal-title":"Front Aging Neurosci"},{"key":"1419_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.679092","volume":"15","author":"PC Chen","year":"2021","unstructured":"Chen PC, Chung CC, Cheng YY, Chen WT, Hong CT, Chan L, Chien LN (2021) Retinal diseases and Parkinson disease: a population-based study. Front Neurosci 15:679092. https:\/\/doi.org\/10.3389\/fnins.2021.679092","journal-title":"Front Neurosci"},{"key":"1419_CR17","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1038\/sj.eye.6702881","volume":"21","author":"MF Cordeiro","year":"2007","unstructured":"Cordeiro MF (2007) DARC: a new method for detecting progressive neuronal death. Eye 21:S15\u2013S17. https:\/\/doi.org\/10.1038\/sj.eye.6702881","journal-title":"Eye"},{"key":"1419_CR18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.preteyeres.2014.07.001","volume":"43","author":"N Cuenca","year":"2014","unstructured":"Cuenca N, Fern\u00e1ndez-S\u00e1nchez L, Campello L, Maneu V, De la Villa P, Lax P, Pinilla I (2014) Cellular responses following retinal injuries and therapeutic approaches for neurodegenerative diseases. Prog Retin Eye Res 43:17\u201375. https:\/\/doi.org\/10.1016\/j.preteyeres.2014.07.001","journal-title":"Prog Retin Eye Res"},{"key":"1419_CR19","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/S1074-7427(03)00008-X","volume":"79","author":"C Da Cunha","year":"2003","unstructured":"Da Cunha C, Wietzikoski S, Wietzikoski EC, Miyoshi E, Ferro MM, Anselmo-Franci JA, Canteras NS (2003) Evidence for the substantia nigra pars compacta as an essential component of a memory system independent of the hippocampal memory system. Neurobiol Learn Mem 79:236\u2013242. https:\/\/doi.org\/10.1016\/S1074-7427(03)00008-X","journal-title":"Neurobiol Learn Mem"},{"key":"1419_CR20","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1093\/brain\/122.8.1421","volume":"122","author":"P Damier","year":"1999","unstructured":"Damier P, Hirsch EC, Agid Y, Graybiel AM (1999) The substantia nigra of the human brain: I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D28K immunohistochemistry. Brain 122:1421\u20131436. https:\/\/doi.org\/10.1093\/brain\/122.8.1421","journal-title":"Brain"},{"key":"1419_CR21","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1126\/science.1087753","volume":"302","author":"TM Dawson","year":"2003","unstructured":"Dawson TM, Dawson VL (2003) Molecular pathways of neurodegeneration in Parkinson\u2019s disease. Science 302:819\u2013822. https:\/\/doi.org\/10.1126\/science.1087753","journal-title":"Science"},{"key":"1419_CR22","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.freeradbiomed.2013.01.018","volume":"62","author":"DT Dexter","year":"2013","unstructured":"Dexter DT, Jenner P (2013) Parkinson disease: from pathology to molecular disease mechanisms. Free Radic Biol Med 62:132\u2013144. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2013.01.018","journal-title":"Free Radic Biol Med"},{"key":"1419_CR23","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.3233\/JPD-181474","volume":"8","author":"ER Dorsey","year":"2018","unstructured":"Dorsey ER, Sherer T, Okun MS, Bloem BR (2018) The emerging evidence of the Parkinson pandemic. J Parkinsons Dis 8:S3\u2013S8. https:\/\/doi.org\/10.3233\/JPD-181474","journal-title":"J Parkinsons Dis"},{"key":"1419_CR24","doi-asserted-by":"publisher","first-page":"612","DOI":"10.3389\/fnins.2018.00612","volume":"12","author":"FN Emamzadeh","year":"2018","unstructured":"Emamzadeh FN, Surguchov A (2018) Parkinson\u2019s disease: biomarkers, treatment, and risk factors. Front Neurosci 12:612. https:\/\/doi.org\/10.3389\/fnins.2018.00612","journal-title":"Front Neurosci"},{"key":"1419_CR25","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1152\/jn.00218.2021","volume":"126","author":"MD Flood","year":"2021","unstructured":"Flood MD, Eggers ED (2021) Dopamine D1 and D4 receptors contribute to light adaptation in ON-sustained retinal ganglion cells. J Neurophysiol 126:2039\u20132052. https:\/\/doi.org\/10.1152\/jn.00218.2021","journal-title":"J Neurophysiol"},{"key":"1419_CR26","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1097\/WCO.0000000000000118","volume":"27","author":"JC Giugni","year":"2014","unstructured":"Giugni JC, Okun MS (2014) Treatment of advanced Parkinson\u2019s disease. Curr Opin Neurol 27:450\u2013460. https:\/\/doi.org\/10.1097\/WCO.0000000000000118","journal-title":"Curr Opin Neurol"},{"key":"1419_CR27","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1210\/en.2007-0980","volume":"149","author":"AE Gonzalez-Iglesias","year":"2008","unstructured":"Gonzalez-Iglesias AE, Murano T, Li S, Tomi\u0107 M, Stojilkovic SS (2008) Dopamine inhibits basal prolactin release in pituitary lactotrophs through pertussis toxin-sensitive and -insensitive signaling pathways. Endocrinology 149:1470\u20131479. https:\/\/doi.org\/10.1210\/en.2007-0980","journal-title":"Endocrinology"},{"key":"1419_CR28","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1001\/archophthalmol.2009.106","volume":"127","author":"ME Hajee","year":"2009","unstructured":"Hajee ME, March WF, Lazzaro DR, Wolintz AH, Shrier EM, Glazman S, Bodis-Wollner IG (2009) Inner retinal layer thinning in Parkinson disease. Arch Ophthalmol 127:737\u2013741. https:\/\/doi.org\/10.1001\/archophthalmol.2009.106","journal-title":"Arch Ophthalmol"},{"key":"1419_CR29","first-page":"2473","volume":"31","author":"C Harnois","year":"1990","unstructured":"Harnois C, Di Paolo T (1990) Decreased dopamine in the retinas of patients with Parkinson\u2019s disease. Investig Ophthalmol vis Sci 31:2473\u20132475","journal-title":"Investig Ophthalmol vis Sci"},{"key":"1419_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2021.102114","volume":"204","author":"M Huang","year":"2021","unstructured":"Huang M, Chen S (2021) DJ-1 in neurodegenerative diseases: pathogenesis and clinical application. Prog Neurobiol 204:102114. https:\/\/doi.org\/10.1016\/j.pneurobio.2021.102114","journal-title":"Prog Neurobiol"},{"key":"1419_CR31","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.neubiorev.2010.02.001","volume":"35","author":"S Ikemoto","year":"2010","unstructured":"Ikemoto S (2010) Brain reward circuitry beyond the mesolimbic dopamine system: a neurobiological theory. Neurosci Biobehav Rev 35:129\u2013150. https:\/\/doi.org\/10.1016\/j.neubiorev.2010.02.001","journal-title":"Neurosci Biobehav Rev"},{"key":"1419_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.567129","volume":"14","author":"A Indrieri","year":"2020","unstructured":"Indrieri A, Pizzarelli R, Franco B, De Leonibus E (2020) Dopamine, alpha-synuclein, and mitochondrial dysfunctions in parkinsonian eyes. Front Neurosci 14:567129. https:\/\/doi.org\/10.3389\/fnins.2020.567129","journal-title":"Front Neurosci"},{"key":"1419_CR33","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/j.1582-4934.2010.01010.x","volume":"14","author":"KA Jellinger","year":"2010","unstructured":"Jellinger KA (2010) Basic mechanisms of neurodegeneration: a critical update. J Cell Mol Med 14:457\u2013487. https:\/\/doi.org\/10.1111\/j.1582-4934.2010.01010.x","journal-title":"J Cell Mol Med"},{"key":"1419_CR34","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/9730467","volume":"2016","author":"H Ju\u00e1rez Olgu\u00edn","year":"2016","unstructured":"Ju\u00e1rez Olgu\u00edn H, Calder\u00f3n Guzm\u00e1n D, Hern\u00e1ndez Garc\u00eda E, Barrag\u00e1n Mej\u00eda G (2016) The role of dopamine and its dysfunction as a consequence of oxidative stress. Oxid Med Cell Longev 2016:9730467. https:\/\/doi.org\/10.1155\/2016\/9730467","journal-title":"Oxid Med Cell Longev"},{"key":"1419_CR35","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1111\/ane.12563","volume":"134","author":"K Kalinderi","year":"2016","unstructured":"Kalinderi K, Bostantjopoulou S, Fidani L (2016) The genetic background of Parkinson\u2019s disease: current progress and future prospects. Acta Neurol Scand 134:314\u2013326. https:\/\/doi.org\/10.1111\/ane.12563","journal-title":"Acta Neurol Scand"},{"key":"1419_CR36","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3389\/fncel.2015.00068","volume":"9","author":"S Karunanithi","year":"2015","unstructured":"Karunanithi S, Brown IR (2015) Heat shock response and homeostatic plasticity. Front Cell Neurosci 9:68. https:\/\/doi.org\/10.3389\/fncel.2015.00068","journal-title":"Front Cell Neurosci"},{"key":"1419_CR37","doi-asserted-by":"crossref","unstructured":"Kirbas S, Turkyilmaz K, Tufekci A, Durmus M (2013) Retinal nerve fiber layer thickness in Parkinson disease. J Neuro-Ophthalmol 33:62\u201365. https:\/\/journals.lww.com\/jneuro-ophthalmology\/Fulltext\/2013\/03000\/Retinal_Nerve_Fiber_Layer_Thickness_in_Parkinson.16.aspx","DOI":"10.1097\/WNO.0b013e3182701745"},{"key":"1419_CR38","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a008888","volume":"2","author":"C Klein","year":"2012","unstructured":"Klein C, Westenberger A (2012) Genetics of Parkinson\u2019s disease. Cold Spring Harb Perspect Med 2:a008888. https:\/\/doi.org\/10.1101\/cshperspect.a008888","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1419_CR39","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/nature04723","volume":"441","author":"M Komatsu","year":"2006","unstructured":"Komatsu M, Waguri S, Chiba T, Murata S, Iwata J, Tanida I, Ueno T, Koike M, Uchiyama Y, Kominami E, Tanaka K (2006) Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 441:880\u2013884. https:\/\/doi.org\/10.1038\/nature04723","journal-title":"Nature"},{"key":"1419_CR40","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/ng0298-106","volume":"18","author":"R Kr\u00fcger","year":"1998","unstructured":"Kr\u00fcger R, Kuhn W, M\u00fcller T, Woitalla D, Graeber M, K\u00f6sel S, Przuntek H, Epplen JT, Schols L, Riess O (1998) AlaSOPro mutation in the gene encoding \u03b1-synuclein in Parkinson\u2019s disease. Nat Genet 18:106\u2013108. https:\/\/doi.org\/10.1038\/ng0298-106","journal-title":"Nat Genet"},{"key":"1419_CR41","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1177\/1073858411385469","volume":"17","author":"NZ Lax","year":"2011","unstructured":"Lax NZ, Turnbull DM, Reeve AK (2011) Mitochondrial mutations: newly discovered players in neuronal degeneration. Neuroscientist 17:645\u2013658. https:\/\/doi.org\/10.1177\/1073858411385469","journal-title":"Neuroscientist"},{"key":"1419_CR42","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1750-1326-9-47","volume":"9","author":"JQ Li","year":"2014","unstructured":"Li JQ, Tan L, Yu JT (2014) The role of the LRRK2 gene in parkinsonism. Mol Neurodegener 9:47. https:\/\/doi.org\/10.1186\/1750-1326-9-47","journal-title":"Mol Neurodegener"},{"key":"1419_CR43","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.brainres.2018.01.010","volume":"1693","author":"RA Liddle","year":"2018","unstructured":"Liddle RA (2018) Parkinson\u2019s disease from the gut. Brain Res 1693:201\u2013206. https:\/\/doi.org\/10.1016\/j.brainres.2018.01.010","journal-title":"Brain Res"},{"key":"1419_CR44","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s12264-017-0183-5","volume":"33","author":"S Lotankar","year":"2017","unstructured":"Lotankar S, Prabhavalkar KS, Bhatt LK (2017) Biomarkers for Parkinson\u2019s disease: recent advancement. Neurosci Bull 33:585\u2013597. https:\/\/doi.org\/10.1007\/s12264-017-0183-5","journal-title":"Neurosci Bull"},{"key":"1419_CR45","first-page":"804","volume":"11","author":"L Magistrelli","year":"2021","unstructured":"Magistrelli L, Contaldi E, Comi C (2021) The impact of SNCA variations and its product alpha-synuclein on non-motor features of Parkinson\u2019s disease. Life (basel) 11:804","journal-title":"Life (basel)"},{"key":"1419_CR46","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40035-017-0099-z","volume":"6","author":"P Maiti","year":"2017","unstructured":"Maiti P, Manna J, Dunbar GL (2017) Current understanding of the molecular mechanisms in Parkinson\u2019s disease: targets for potential treatments. Transl Neurodegener 6:28. https:\/\/doi.org\/10.1186\/s40035-017-0099-z","journal-title":"Transl Neurodegener"},{"key":"1419_CR47","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41598-019-57196-y","volume":"10","author":"EB Mariottoni","year":"2020","unstructured":"Mariottoni EB, Jammal AA, Urata CN, Berchuck SI, Thompson AC, Estrela T, Medeiros FA (2020) Quantification of retinal nerve fibre layer thickness on optical coherence tomography with a deep learning segmentation-free approach. Sci Rep 10:402. https:\/\/doi.org\/10.1038\/s41598-019-57196-y","journal-title":"Sci Rep"},{"key":"1419_CR48","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/35086067","volume":"2","author":"KSP McNaught","year":"2001","unstructured":"McNaught KSP, Olanow CW, Halliwell B, Isacson O, Jenner P (2001) Failure of the ubiquitin\u2013proteasome system in Parkinson\u2019s disease. Nat Rev Neurosci 2:589\u2013594. https:\/\/doi.org\/10.1038\/35086067","journal-title":"Nat Rev Neurosci"},{"key":"1419_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.633752","volume":"13","author":"J Mei","year":"2021","unstructured":"Mei J, Desrosiers C, Frasnelli J (2021) Machine learning for the diagnosis of Parkinson\u2019s disease: a review of literature. Front Aging Neurosci 13:633752. https:\/\/doi.org\/10.3389\/fnagi.2021.633752","journal-title":"Front Aging Neurosci"},{"key":"1419_CR50","doi-asserted-by":"publisher","DOI":"10.1177\/1179069518779829","volume":"12","author":"A Mishra","year":"2018","unstructured":"Mishra A, Singh S, Shukla S (2018) Physiological and functional basis of dopamine receptors and their role in neurogenesis: possible implication for Parkinson\u2019s disease. J Exp Neurosci 12:1179069518779829. https:\/\/doi.org\/10.1177\/1179069518779829","journal-title":"J Exp Neurosci"},{"key":"1419_CR51","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s13760-020-01274-w","volume":"120","author":"S Mohana Devi","year":"2020","unstructured":"Mohana Devi S, Mahalaxmi I, Aswathy NP, Dhivya V, Balachandar V (2020) Does retina play a role in Parkinson\u2019s disease? Acta Neurol Belg 120:257\u2013265. https:\/\/doi.org\/10.1007\/s13760-020-01274-w","journal-title":"Acta Neurol Belg"},{"key":"1419_CR52","doi-asserted-by":"publisher","first-page":"103","DOI":"10.5607\/en.2015.24.2.103","volume":"24","author":"HE Moon","year":"2015","unstructured":"Moon HE, Paek SH (2015) Mitochondrial dysfunction in Parkinson\u2019s disease. Exp Neurobiol 24:103\u2013116. https:\/\/doi.org\/10.5607\/en.2015.24.2.103","journal-title":"Exp Neurobiol"},{"key":"1419_CR53","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/emmm.200900006","volume":"1","author":"VA Morais","year":"2009","unstructured":"Morais VA, Verstreken P, Roethig A, Smet J, Snellinx A, Vanbrabant M, Haddad D, Frezza C, Mandemakers W, Vogt-Weisenhorn D, Van Coster R, Wurst W, Scorrano L, De Strooper B (2009) Parkinson\u2019s disease mutations in PINK1 result in decreased Complex I activity and deficient synaptic function. EMBO Mol Med 1:99\u2013111. https:\/\/doi.org\/10.1002\/emmm.200900006","journal-title":"EMBO Mol Med"},{"key":"1419_CR54","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1089\/ars.2010.3799","volume":"14","author":"DP Narendra","year":"2011","unstructured":"Narendra DP, Youle RJ (2011) Targeting mitochondrial dysfunction: role for PINK1 and Parkin in mitochondrial quality control. Antioxid Redox Signal 14:1929\u20131938. https:\/\/doi.org\/10.1089\/ars.2010.3799","journal-title":"Antioxid Redox Signal"},{"key":"1419_CR55","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1081\/RRS-200029981","volume":"24","author":"KA Neve","year":"2004","unstructured":"Neve KA, Seamans JK, Trantham-Davidson H (2004) Dopamine receptor signaling. J Recept Signal Transduct 24:165\u2013205. https:\/\/doi.org\/10.1081\/RRS-200029981","journal-title":"J Recept Signal Transduct"},{"key":"1419_CR56","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1146\/annurev.neuro.23.1.185","volume":"23","author":"SM Nicola","year":"2000","unstructured":"Nicola SM, Surmeier DJ, Malenka RC (2000) Dopaminergic modulation of neuronal excitability in the striatum and nucleus accumbens. Annu Rev Neurosci 23:185\u2013215. https:\/\/doi.org\/10.1146\/annurev.neuro.23.1.185","journal-title":"Annu Rev Neurosci"},{"key":"1419_CR57","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1136\/jnnp.49.11.1280","volume":"49","author":"S Nightingale","year":"1986","unstructured":"Nightingale S, Mitchell KW, Howe JW (1986) Visual evoked cortical potentials and pattern electroretinograms in Parkinson\u2019s disease and control subjects. J Neurol Neurosurg Psychiatry 49:1280\u20131287. https:\/\/doi.org\/10.1136\/jnnp.49.11.1280","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1419_CR58","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s40478-016-0346-z","volume":"4","author":"EM Normando","year":"2016","unstructured":"Normando EM, Davis BM, De Groef L, Nizari S, Turner LA, Ravindran N, Pahlitzsch M, Brenton J, Malaguarnera G, Guo L, Somavarapu S, Cordeiro MF (2016) The retina as an early biomarker of neurodegeneration in a rotenone-induced model of Parkinson\u2019s disease: evidence for a neuroprotective effect of rosiglitazone in the eye and brain. Acta Neuropathol Commun 4:86. https:\/\/doi.org\/10.1186\/s40478-016-0346-z","journal-title":"Acta Neuropathol Commun"},{"key":"1419_CR59","doi-asserted-by":"publisher","first-page":"502","DOI":"10.2174\/1389202914666131210205839","volume":"14","author":"A Oczkowska","year":"2013","unstructured":"Oczkowska A, Kozubski W, Lianeri M, Dorszewska J (2013) Mutations in PRKN and SNCA genes important for the progress of Parkinson\u2019s disease. Curr Genom 14:502\u2013517. https:\/\/doi.org\/10.2174\/1389202914666131210205839","journal-title":"Curr Genom"},{"key":"1419_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J, Schrag AE, Lang AE (2017) Parkinson disease. Nat Rev Dis Primers 3:17013. https:\/\/doi.org\/10.1038\/nrdp.2017.13","journal-title":"Nat Rev Dis Primers"},{"key":"1419_CR61","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"76","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH, Lavedan C, Leroy E et al (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease. Science 76:2045\u20132047. https:\/\/doi.org\/10.1126\/science.276.5321.2045","journal-title":"Science"},{"key":"1419_CR62","volume-title":"Organ Retin Vis Syst","author":"E Popova","year":"2020","unstructured":"Popova E (2020) Role of dopamine in retinal function. In: Kolb H, Fernandez E, Nelson R (eds) Organ Retin Vis Syst. University of Utah, Salt Lake City"},{"key":"1419_CR63","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/9957132","volume":"2021","author":"M Pramanik","year":"2021","unstructured":"Pramanik M, Pradhan R, Nandy P, Qaisar SM, Bhoi AK (2021) Assessment of acoustic features and machine learning for Parkinson\u2019s detection. J Healthc Eng 2021:9957132. https:\/\/doi.org\/10.1155\/2021\/9957132","journal-title":"J Healthc Eng"},{"key":"1419_CR64","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.615461","volume":"8","author":"J Prasuhn","year":"2021","unstructured":"Prasuhn J, Davis RL, Kumar KR (2021) Targeting mitochondrial impairment in Parkinson\u2019s disease: challenges and opportunities. Front Cell Dev Biol 8:615461. https:\/\/doi.org\/10.3389\/fcell.2020.615461","journal-title":"Front Cell Dev Biol"},{"key":"1419_CR65","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3389\/fncel.2015.00163","volume":"9","author":"B Puka\u00df","year":"2015","unstructured":"Puka\u00df B, Richter-Landsberg C (2015) Inhibition of UCH-L1 in oligodendroglial cells results in microtubule stabilization and prevents \u03b1-synuclein aggregate formation by activating the autophagic pathway: implications for multiple system atrophy. Front Cell Neurosci 9:163. https:\/\/doi.org\/10.3389\/fncel.2015.00163","journal-title":"Front Cell Neurosci"},{"key":"1419_CR66","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s40478-020-01062-w","volume":"8","author":"PMJ Quinn","year":"2020","unstructured":"Quinn PMJ, Moreira PI, Ambr\u00f3sio AF, Alves HC (2020) PINK1\/PARKIN signalling in neurodegeneration and neuroinflammation. Acta Neuropathol Commun 8:189. https:\/\/doi.org\/10.1186\/s40478-020-01062-w","journal-title":"Acta Neuropathol Commun"},{"key":"1419_CR67","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.3389\/fnins.2019.01028","volume":"13","author":"M Ramalingam","year":"2019","unstructured":"Ramalingam M, Huh YJ, Lee YI (2019) The impairments of \u03b1-synuclein and mechanistic target of rapamycin in rotenone-induced SH-SY5Y cells and mice model of Parkinson\u2019s disease. Front Neurosci 13:1028. https:\/\/doi.org\/10.3389\/fnins.2019.01028","journal-title":"Front Neurosci"},{"key":"1419_CR68","doi-asserted-by":"publisher","DOI":"10.1177\/25158414211002400","volume":"13","author":"MJ Ringel","year":"2021","unstructured":"Ringel MJ, Tang EM, Tao YK (2021) Advances in multimodal imaging in ophthalmology. Ther Adv Ophthalmol 13:25158414211002400. https:\/\/doi.org\/10.1177\/25158414211002400","journal-title":"Ther Adv Ophthalmol"},{"key":"1419_CR69","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1001\/jamaophthalmol.2020.5730","volume":"139","author":"CB Robbins","year":"2021","unstructured":"Robbins CB, Thompson AC, Bhullar PK, Koo HY, Agrawal R, Soundararajan S, Yoon SP, Polascik BW, Scott BL, Grewal DS, Fekrat S (2021) Characterization of retinal microvascular and choroidal structural changes in Parkinson disease. JAMA Ophthalmol 139:82\u2013188. https:\/\/doi.org\/10.1001\/jamaophthalmol.2020.5730","journal-title":"JAMA Ophthalmol"},{"key":"1419_CR70","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40708-020-00113-1","volume":"7","author":"MSR Sajal","year":"2020","unstructured":"Sajal MSR, Ehsan MT, Vaidyanathan R, Wang S, Aziz T, Al Mamun KA (2020) Telemonitoring Parkinson\u2019s disease using machine learning by combining tremor and voice analysis. Brain Inform 7:12. https:\/\/doi.org\/10.1186\/s40708-020-00113-1","journal-title":"Brain Inform"},{"key":"1419_CR71","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.neuint.2013.06.005","volume":"63","author":"S Sharma","year":"2013","unstructured":"Sharma S, Moon CS, Khogali A, Haidous A, Chabenne A, Ojo C, Jelebinkov M, Kurdi Y, Ebadi M (2013) Biomarkers in Parkinson\u2019s disease (recent update). Neurochem Int 63:201\u2013229. https:\/\/doi.org\/10.1016\/j.neuint.2013.06.005","journal-title":"Neurochem Int"},{"key":"1419_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2019.101748","volume":"22","author":"S Shinde","year":"2019","unstructured":"Shinde S, Prasad S, Saboo Y, Kaushick R, Saini J, Pal PK, Ingalhalikar M (2019) Predictive markers for Parkinson\u2019s disease using deep neural nets on neuromelanin sensitive MRI. NeuroImage Clin 22:101748. https:\/\/doi.org\/10.1016\/j.nicl.2019.101748","journal-title":"NeuroImage Clin"},{"key":"1419_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.ailsci.2021.100018","volume":"1","author":"MD Subramaniam","year":"2021","unstructured":"Subramaniam MD, Kumar A, Chirayath RB, Nair AP, Iyer M, Vellingiri B (2021) Can deep learning revolutionize clinical understanding and diagnosis of optic neuropathy? Artif Intell Life Sci 1:100018. https:\/\/doi.org\/10.1016\/j.ailsci.2021.100018","journal-title":"Artif Intell Life Sci"},{"key":"1419_CR74","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.645293","volume":"8","author":"T Tabashum","year":"2021","unstructured":"Tabashum T, Zaffer A, Yousefzai R, Colletta K, Jost MB, Park Y, Chawla J, Gaynes B, Albert MV, Xiao T (2021) Detection of Parkinson\u2019s disease through automated pupil tracking of the post-illumination pupillary response. Front Med 8:645293. https:\/\/doi.org\/10.3389\/fmed.2021.645293","journal-title":"Front Med"},{"key":"1419_CR75","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1109\/TBME.2020.3043215","volume":"68","author":"KA Thakoor","year":"2021","unstructured":"Thakoor KA, Koorathota SC, Hood DC, Sajda P (2021) Robust and interpretable convolutional neural networks to detect glaucoma in optical coherence tomography images. IEEE Trans Biomed Eng 68:2456\u20132466. https:\/\/doi.org\/10.1109\/TBME.2020.3043215","journal-title":"IEEE Trans Biomed Eng"},{"key":"1419_CR76","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3980\/j.issn.2222-3959.2011.04.21","volume":"4","author":"T Tian","year":"2011","unstructured":"Tian T, Zhu XH, Liu YH (2011) Potential role of retina as a biomarker for progression of Parkinson\u2019s disease. Int J Ophthalmol 4:433\u2013438. https:\/\/doi.org\/10.3980\/j.issn.2222-3959.2011.04.21","journal-title":"Int J Ophthalmol"},{"key":"1419_CR77","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/nature11466","volume":"490","author":"NX Tritsch","year":"2012","unstructured":"Tritsch NX, Ding JB, Sabatini BL (2012) Dopaminergic neurons inhibit striatal output through non-canonical release of GABA. Nature 490:262\u2013266. https:\/\/doi.org\/10.1038\/nature11466","journal-title":"Nature"},{"key":"1419_CR78","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1046\/j.1460-9568.2000.00910.x","volume":"12","author":"KY Tseng","year":"2000","unstructured":"Tseng KY, Riquelme LA, Belforte JE, Pazo JH, Murer MG (2000) Substantia nigra pars reticulata units in 6-hydroxydopamine-lesioned rats: responses to striatal D2 dopamine receptor stimulation and subthalamic lesions. Eur J Neurosci 12:247\u2013256. https:\/\/doi.org\/10.1046\/j.1460-9568.2000.00910.x","journal-title":"Eur J Neurosci"},{"key":"1419_CR79","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/B978-0-12-820649-2.00289-8","volume-title":"Handbook of hormones","author":"T Ubuka","year":"2021","unstructured":"Ubuka T (2021) Subchapter 131A\u2014dopamine. In: Ando H, Ukena K (eds) Handbook of hormones. Academic Press, San Diego, pp 1037\u20131039. https:\/\/doi.org\/10.1016\/B978-0-12-820649-2.00289-8"},{"key":"1419_CR80","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.pharmthera.2010.05.003","volume":"128","author":"AS Undieh","year":"2010","unstructured":"Undieh AS (2010) Pharmacology of signaling induced by dopamine D(1)-like receptor activation. Pharmacol Ther 128:37\u201360. https:\/\/doi.org\/10.1016\/j.pharmthera.2010.05.003","journal-title":"Pharmacol Ther"},{"key":"1419_CR81","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1126\/science.6823561","volume":"219","author":"LJ William","year":"1983","unstructured":"William LJ, Philip B, Tetrud JJ, Ian I (1983) Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219:979\u2013980. https:\/\/doi.org\/10.1126\/science.6823561","journal-title":"Science"},{"key":"1419_CR82","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1023\/b:doop.0000019487.88486.0a","volume":"108","author":"P Witkovsky","year":"2004","unstructured":"Witkovsky P (2004) Dopamine and retinal function. Doc Ophthalmol 108:17\u201340. https:\/\/doi.org\/10.1023\/b:doop.0000019487.88486.0a","journal-title":"Doc Ophthalmol"},{"key":"1419_CR83","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1136\/jnnp.2003.020982","volume":"75","author":"GF Wooten","year":"2004","unstructured":"Wooten GF, Currie LJ, Bovbjerg VE, Lee JK, Patrie J (2004) Are men at greater risk for Parkinson\u2019s disease than women? J Neurol Neurosurg Psychiatry 75:637\u2013639. https:\/\/doi.org\/10.1136\/jnnp.2003.020982","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1419_CR84","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0085718","volume":"9","author":"J Yu","year":"2014","unstructured":"Yu J, Feng Y, Xiang Y, Huang J, Savini G, Parisi V, Yang W, Fu X (2014) Retinal nerve fiber layer thickness changes in Parkinson disease: a meta-analysis. PLoS\u00a0ONE 9:e85718. https:\/\/doi.org\/10.1371\/journal.pone.0085718","journal-title":"PLoS\u00a0ONE"},{"key":"1419_CR85","unstructured":"Zecca L, Tampellini D, Gerlach M, Riederer P, Fariello RG, Sulzer D (2001) Substantia nigra neuromelanin: structure, synthesis, and molecular behaviour. Mol Pathol 54:414\u2013418. https:\/\/pubmed.ncbi.nlm.nih.gov\/11724917."},{"key":"1419_CR86","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.cell.2021.01.027","volume":"184","author":"Y Zhuang","year":"2021","unstructured":"Zhuang Y, Xu P, Mao C, Wang L, Krumm B, Zhou XE, Huang S et al (2021) Structural insights into the human D1 and D2 dopamine receptor signalling complexes. Cell 184:931-942.e18. https:\/\/doi.org\/10.1016\/j.cell.2021.01.027","journal-title":"Cell"},{"key":"1419_CR87","doi-asserted-by":"publisher","first-page":"168","DOI":"10.5114\/fn.2017.68584","volume":"55","author":"M \u017divkovi\u0107","year":"2017","unstructured":"\u017divkovi\u0107 M, Dayanir V, Stamenovi\u0107 J, Ljubisavljevi\u0107 S, Pra\u017ei\u0107 A, Zlatanovi\u0107 M, Zlatanovi\u0107 G, Jak\u0161i\u0107 V, Radenkovi\u0107 M, Jovanovi\u0107 S (2017) Retinal ganglion cell\/inner plexiform layer thickness in patients with Parkinson\u2019s disease. Folia Neuropathol 55:168\u2013173. https:\/\/doi.org\/10.5114\/fn.2017.68584","journal-title":"Folia Neuropathol"}],"container-title":["Cellular and Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-023-01419-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10571-023-01419-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-023-01419-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T01:12:40Z","timestamp":1700529160000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10571-023-01419-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,13]]},"references-count":87,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["1419"],"URL":"https:\/\/doi.org\/10.1007\/s10571-023-01419-4","relation":{},"ISSN":["0272-4340","1573-6830"],"issn-type":[{"value":"0272-4340","type":"print"},{"value":"1573-6830","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,13]]},"assertion":[{"value":"28 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}